Prevention, Diagnosis, Treatment and Healthcare for the People with Neurodegenerative Diseases
Deadline for manuscript submissions: 30 June 2024 | Viewed by 3047
2. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, 14186 Stockholm, Sweden
Interests: neuroepidemiology; clinical neuroscience; neurodegenerative disorders; neuroimaging; Parkinson's disease; neuro-prevention
Neurodegenerative disorders are a heterogenous group of neurologic entities with various pathogenesis consisting of proteinopathies (e.g., Parkinson’s disease, Alzheimer’s disease, other dementias), motor neuron diseases (e.g., amyotrophic lateral sclerosis (ALS)), autoimmune-related (e.g., multiple sclerosis), or genetic disorders (e.g., Huntington's disease, spinocerebellar ataxia (SCA)). Neurodegenerative diseases are progressive, with debilitating consequences affecting motor, cognitive, and behavioural performances. The burden of these diseases, particularly age-related proteinopathies (e.g., Parkinson’s disease and Alzheimer’s disease), is steadily increasing in most countries, mainly due to population ageing and longevity. Due to multi-domain involvement, chronicity and progressive course, caring for people with neurodegenerative diseases is highly complex. Even though many of the neurodegenerative diseases (i.e., Parkinson’s disease and Alzheimer’s disease) are preceded by a long prodromal stage of up to 1–2 decades prior to the presence of debilitating motor or cognitive symptoms, there is currently no neuroprotective agent that can reverse or halt their pathogenesis. Furthermore, disease modifying treatments only exist for certain conditions, such as multiple sclerosis.
This Special Issue seeks manuscripts that address different aspects of neurodegenerative diseases, namely prevention, diagnosis, symptomatic and/or disease modifying treatments, as well as multidisciplinary management and care plans. Original articles and reviews will be considered. Papers tackling the themes of prevention, novel diagnostic biomarkers, treatments and the latest advances in the management of neurodegenerative diseases using a multidisciplinary approach are of particular interest.
This Special Issue aims to provide an updated panorama of the current state of the art and future healthcare trends to reduce the global burden of neurodegenerative diseases.
Dr. Seyed Mohammad Fereshtehnejad
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- disease modifying treatment
- neurodegenerative diseases
- Alzheimer’s disease and other dementias
- Parkinson’s disease
- motor neuron disease
- multiple system atrophy
- progressive supranuclear palsy
- multiple sclerosis
- Huntington's disease